GBIO vs GOEV
Generation Bio Co (GBIO) versus GOEV (GOEV) — a side-by-side from cached financials, not a winner call.
Generation Bio Co (GBIO) is a biotechnology company listed on US.
GOEV (GOEV) common stock.
Latest reported GBIO revenue for 2024-12-31 was $19.9M. Net income was -$131.7M. Revenue was up 236.9% from 2023-12-31 to 2024-12-31. GBIO currently screens at market cap $25.4M.
GOEV does not have a complete income-statement cache yet.
GBIO currently screens at market cap $25.4M.
Not investment advice. Open the GBIO and GOEV stock pages for the full models.
Not investment advice.